Roche Seeks Fast-Track US Approval of Ebola Diagnostic Test

A rapid diagnostic test for Ebola has been developed by Swiss pharmaceutical group Roche and hopes to obtain fast-tract US approval for it, its director general said Sunday.

A rapid diagnostic test for Ebola has been developed by Swiss pharmaceutical group Roche and hopes to obtain fast-track US approval for it. The company’s director general declared this in an interview published Sunday, amid the worst-ever outbreak of the killer disease.

The diagnostic test is ready for use in scientific research but the company now wants to register it for clinical use.

Quiz on Ebola
Why is the deadly Ebola virus outbreak making the health experts hit the panic button? Find out from this quiz.

Roche has filed for European Union approval of the test and plans shortly to do the same with US health authorities, CEO Severin Schwan told the Swiss German SonntagsZeitung newspaper.

"We hope that they will grant us an accelerated authorization procedure," Schwan said.

More than 10,000 people have contracted the Ebola virus, according to the latest World Health Organization figures, mainly in the west African countries of Liberia, Sierra Leone and Guinea.

Ebola Virus Disease | Ebola Hemorrhagic Fever: Cause Symptoms Diagnosis Treatment
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have identified five types of Ebola or Ebola hemorrhagic fever virus.

More than 4,900 people have died of the hemorrhagic virus, according to the figures from October 23.

Source-AFP

Ebola-Wary American Public Get Reassurance from Obama
Americans must be guided by the facts, not fear when it comes to the deadly Ebola virus, President Barack Obama told his countrymen on Saturday.

Big Data Becomes Tool in Ebola Epidemic
A group of researchers and computer scientists in Boston spotted the hemorrhagic fever beginning to spread in Guinea, nine days before Ebola was declared an epidemic.